Lynx1 Capital Management Lp - Net Worth and Insider Trading
Lynx1 Capital Management Lp Net Worth
The estimated net worth of Lynx1 Capital Management Lp is at least $45 Million dollars as of 2024-05-03. Lynx1 Capital Management Lp is the 10% Owner of TScan Therapeutics Inc and owns about 5,224,600 shares of TScan Therapeutics Inc (TCRX) stock worth over $45 Million. Details can be seen in Lynx1 Capital Management Lp's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Lynx1 Capital Management Lp has not made any transactions after 2023-05-31 and currently still holds the listed stock(s).
Transaction Summary of Lynx1 Capital Management Lp
Lynx1 Capital Management Lp Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Lynx1 Capital Management Lp owns 1 companies in total, including TScan Therapeutics Inc (TCRX) .
Click here to see the complete history of Lynx1 Capital Management Lp’s form 4 insider trades.
Insider Ownership Summary of Lynx1 Capital Management Lp
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TCRX | TScan Therapeutics Inc | 2023-05-31 | 10 percent owner |
Lynx1 Capital Management Lp Latest Holdings Summary
Lynx1 Capital Management Lp currently owns a total of 1 stock. Lynx1 Capital Management Lp owns 5,224,600 shares of TScan Therapeutics Inc (TCRX) as of May 31, 2023, with a value of $45 Million.
Latest Holdings of Lynx1 Capital Management Lp
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TCRX | TScan Therapeutics Inc | 2023-05-31 | 5,224,600 | 8.65 | 45,192,790 |
Holding Weightings of Lynx1 Capital Management Lp
Lynx1 Capital Management Lp Form 4 Trading Tracker
According to the SEC Form 4 filings, Lynx1 Capital Management Lp has made a total of 1 transactions in TScan Therapeutics Inc (TCRX) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in TScan Therapeutics Inc is the sale of 25,400 shares on May 31, 2023, which brought Lynx1 Capital Management Lp around $64,008.
Insider Trading History of Lynx1 Capital Management Lp
- 1
Lynx1 Capital Management Lp Trading Performance
Lynx1 Capital Management Lp Ownership Network
Lynx1 Capital Management Lp Owned Company Details
What does TScan Therapeutics Inc do?
Who are the key executives at TScan Therapeutics Inc?
Lynx1 Capital Management Lp is the 10 percent owner of TScan Therapeutics Inc. Other key executives at TScan Therapeutics Inc include Chief Accounting Officer Leiden Dworak , 10 percent owner Weston Nichols , and 10 percent owner Ecor1 Capital, Llc .
TScan Therapeutics Inc (TCRX) Insider Trades Summary
Over the past 18 months, Lynx1 Capital Management Lp made 1 insider transaction in TScan Therapeutics Inc (TCRX) with a net sale of 25,400. Other recent insider transactions involving TScan Therapeutics Inc (TCRX) include a net purchase of 67,027 shares made by Timothy J Barberich , a net purchase of 6,000 shares made by Brian M. Silver , and a net purchase of 5,000 shares made by Barbara Klencke .
In summary, during the past 3 months, insiders sold 0 shares of TScan Therapeutics Inc (TCRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 25,400 shares of TScan Therapeutics Inc (TCRX) were sold and 78,027 shares were bought by its insiders, resulting in a net purchase of 52,627 shares.
TScan Therapeutics Inc (TCRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
TScan Therapeutics Inc Insider Transactions
Lynx1 Capital Management Lp Mailing Address
Above is the net worth, insider trading, and ownership report for Lynx1 Capital Management Lp. You might contact Lynx1 Capital Management Lp via mailing address: 151 Calle De San Francisco, Suite 200 Pmb 1237, San Juan Pr 00901-1607.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
